These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 29049220)

  • 21. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.
    Wang L; Wang Z; Gao X; Li X; Sun X; Liu C
    Tumour Biol; 2014 Feb; 35(2):1149-55. PubMed ID: 24186074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
    Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
    Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.
    Lu C; Dong J; Ma H; Jin G; Hu Z; Peng Y; Guo X; Wang X; Shen H
    Breast Cancer Res Treat; 2009 Aug; 116(3):571-5. PubMed ID: 18819000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
    Sergentanis TN; Economopoulos KP
    Mol Biol Rep; 2011 Nov; 38(8):4955-63. PubMed ID: 21161398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A trial sequential meta-analysis of
    Mandal RK; Khan MA; Hussain A; Akhter N; Jawed A; Dar SA; Wahid M; Panda AK; Lohani M; Mishra BN; Haque S
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
    Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
    Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
    Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
    Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis.
    Meng Y; Zhang C; Zhou X
    Onco Targets Ther; 2016; 9():367-76. PubMed ID: 26855585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population.
    Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
    Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
    Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis.
    Wen L; Hu YY; Yang GL; Liu DX
    Biomed Rep; 2014 Jul; 2(4):549-554. PubMed ID: 24944806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
    Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
    Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.
    Cui J; Shen L; Wang Y
    Asian Pac J Cancer Prev; 2012; 13(10):5023-5. PubMed ID: 23244103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between the hOGG1 1245C>G (rs1052133) Polymorphism and Susceptibility to Colorectal Cancer: a Meta-analysis Based on 7010 Cases and 10,674 Controls.
    Ghelmani Y; Asadian F; Antikchi MH; Dastgheib SA; Shaker SH; Jafari-Nedooshan J; Neamatzadeh H
    J Gastrointest Cancer; 2021 Jun; 52(2):389-398. PubMed ID: 33025423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study.
    Sameer AS; Parray FQ; Dar MA; Nissar S; Banday MZ; Rasool S; Gulzar GM; Chowdri NA; Siddiqi MA
    Mol Med Rep; 2013 Mar; 7(3):811-5. PubMed ID: 23354584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
    Li J; Luo F; Zhang H; Li L; Xu Y
    Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis.
    Zhao Y; He HR; Wang MY; Ren XD; Zhang L; Dong YL; Lu J
    Genet Mol Res; 2015 May; 14(2):5171-80. PubMed ID: 26125710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.
    Zheng M; Wan L; He X; Qi X; Liu F; Zhang DH
    World J Surg Oncol; 2015 Feb; 13():55. PubMed ID: 25888980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.